Cargando…
Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells
Allogeneic gene products of the major histocompatibility complex, the HLA complex in man and the H–2 complex in mice, induce T lymphocytes to exert powerful mixed lymphocyte reactions (MLR) and cell-mediated lympholysis (CML). In mice, the subset of T cells carrying the L3T4 surface antigen but lack...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095433/ https://www.ncbi.nlm.nih.gov/pubmed/3090451 http://dx.doi.org/10.1038/322541a0 |
_version_ | 1783510669387104256 |
---|---|
author | Sprent, J. Schaefer, Mary |
author_facet | Sprent, J. Schaefer, Mary |
author_sort | Sprent, J. |
collection | PubMed |
description | Allogeneic gene products of the major histocompatibility complex, the HLA complex in man and the H–2 complex in mice, induce T lymphocytes to exert powerful mixed lymphocyte reactions (MLR) and cell-mediated lympholysis (CML). In mice, the subset of T cells carrying the L3T4 surface antigen but lacking the Lyt-2 antigen responds predominantly to H–2 class II (la) differences whereas the L3T4(−) Lyt-2(+) subset reacts to class I (K/D) differences(1,2). For primary responses the stimulus for MLR and CML appears to be controlled by Ia(+) cells of the macrophage/dendritic cell lineages, for both L3T4(+) and Lyt-2(+) cells(3–6). The finding that la(+) cells are required for responses involving Lyt-2(+) cells has been taken to imply that triggering of these cells is controlled by la-restricted L3T4(+) cells(7,8). Lyt-2(+) cells have thus come to be regarded as crippled cells which are heavily dependent on ‘help’ from other T cells(9–11). This well-entrenched view is challenged by evidence presented here that purified Lyt-2(+) cells can give high primary responses to certain Ia(−) tumour cells in vitro. |
format | Online Article Text |
id | pubmed-7095433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1986 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70954332020-03-26 Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells Sprent, J. Schaefer, Mary Nature Article Allogeneic gene products of the major histocompatibility complex, the HLA complex in man and the H–2 complex in mice, induce T lymphocytes to exert powerful mixed lymphocyte reactions (MLR) and cell-mediated lympholysis (CML). In mice, the subset of T cells carrying the L3T4 surface antigen but lacking the Lyt-2 antigen responds predominantly to H–2 class II (la) differences whereas the L3T4(−) Lyt-2(+) subset reacts to class I (K/D) differences(1,2). For primary responses the stimulus for MLR and CML appears to be controlled by Ia(+) cells of the macrophage/dendritic cell lineages, for both L3T4(+) and Lyt-2(+) cells(3–6). The finding that la(+) cells are required for responses involving Lyt-2(+) cells has been taken to imply that triggering of these cells is controlled by la-restricted L3T4(+) cells(7,8). Lyt-2(+) cells have thus come to be regarded as crippled cells which are heavily dependent on ‘help’ from other T cells(9–11). This well-entrenched view is challenged by evidence presented here that purified Lyt-2(+) cells can give high primary responses to certain Ia(−) tumour cells in vitro. Nature Publishing Group UK 1986 /pmc/articles/PMC7095433/ /pubmed/3090451 http://dx.doi.org/10.1038/322541a0 Text en © Nature Publishing Group 1986 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Sprent, J. Schaefer, Mary Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells |
title | Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells |
title_full | Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells |
title_fullStr | Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells |
title_full_unstemmed | Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells |
title_short | Capacity of purified Lyt-2(+) T cells to mount primary proliferative and cytotoxic responses to Ia(−) tumour cells |
title_sort | capacity of purified lyt-2(+) t cells to mount primary proliferative and cytotoxic responses to ia(−) tumour cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095433/ https://www.ncbi.nlm.nih.gov/pubmed/3090451 http://dx.doi.org/10.1038/322541a0 |
work_keys_str_mv | AT sprentj capacityofpurifiedlyt2tcellstomountprimaryproliferativeandcytotoxicresponsestoiatumourcells AT schaefermary capacityofpurifiedlyt2tcellstomountprimaryproliferativeandcytotoxicresponsestoiatumourcells |